About
Founded in 2015, HoneyNaps is a digital healthcare company headquartered in Seoul, Korea with a U.S. presence in Boston, MA. The company develops cutting-edge technologies centered on bio-signal monitoring, sleep disorder assessment, and AI-based disease diagnosis — with an FDA-certified AI Sleep Data Diagnosis Algorithm at its core. Their flagship platform, SOMNUM, serves as a full-cycle bio-signal management and disease prediction solution, enabling seamless data collection, real-time monitoring, and advanced analytics. HoneyNaps operates on the principle of 4P Medicine — Prevention, Prediction, Participation, and Personalization — aiming to democratize access to precision healthcare. Key capabilities include a real-time sleep bio-signal monitoring system, a comprehensive bio-signal management and analysis platform, AI-driven disease diagnosis software, and therapeutic care programs targeting sleep disorders. The platform is designed to be accessible to medical professionals, clinical researchers, and healthcare institutions seeking to integrate intelligent bio-signal insights into patient care workflows. HoneyNaps collaborates with leading academic institutions such as Yonsei University for R&D, ensuring its technologies are grounded in rigorous scientific research. It is positioned as an enterprise-grade solution for organizations looking to advance digital health initiatives and deliver personalized, preventative patient outcomes.
Key Features
- FDA-Certified AI Diagnosis Algorithm: Proprietary AI algorithm certified by the FDA to analyze sleep data and support clinical disease diagnosis with high accuracy.
- Real-Time Bio-Signal Monitoring: Continuously monitors bio-signals during sleep, providing live data streams for medical professionals and researchers.
- SOMNUM Platform: A full-cycle bio-signal management and disease prediction platform enabling data collection, analysis, and AI-powered insights in one unified system.
- AI-Based Disease Prediction: Leverages machine learning models trained on sleep and bio-signal data to predict health conditions and support early intervention.
- Therapeutic Sleep Disorder Care: Offers therapeutic programs and clinical tools specifically designed to assess and treat sleep disorders.
Use Cases
- Clinical sleep disorder assessment and diagnosis using real-time AI-analyzed bio-signal data.
- Hospital and healthcare institution deployment of AI-driven disease prediction models for preventative care.
- Academic and medical research into bio-signal patterns and sleep-related health conditions.
- Personalized patient monitoring programs built around 4P Medicine principles (Prevention, Prediction, Participation, Personalization).
- Development of digital therapeutics and remote patient monitoring workflows for sleep health management.
Pros
- FDA-Certified Technology: The AI diagnosis algorithm carries FDA certification, lending it credibility and regulatory trustworthiness for clinical deployment.
- Comprehensive Bio-Signal Platform: SOMNUM covers the full cycle from real-time monitoring to disease prediction, reducing the need for multiple disparate tools.
- Academic & Research Collaboration: Partnership with Yonsei University ensures the technology is backed by rigorous scientific research and continuous innovation.
Cons
- Limited Public Pricing Transparency: Pricing and access details are not publicly disclosed, requiring direct contact for enterprise inquiries.
- Specialized Use Case: The platform is primarily designed for healthcare institutions and researchers, making it less accessible for general consumers or small clinics.
Frequently Asked Questions
What is HoneyNaps' core technology?
HoneyNaps' core technology is an FDA-certified AI algorithm for sleep data diagnosis, integrated into their SOMNUM platform for real-time bio-signal monitoring and disease prediction.
Who is HoneyNaps designed for?
HoneyNaps targets medical professionals, clinical researchers, and healthcare institutions looking to leverage AI-driven insights for sleep disorder assessment and disease prevention.
What is the SOMNUM platform?
SOMNUM is HoneyNaps' flagship platform that provides full-cycle bio-signal management — from real-time data collection and monitoring to AI-powered analysis and disease prediction.
Is HoneyNaps FDA approved?
Yes, HoneyNaps has developed an FDA-certified AI Sleep Data Diagnosis Algorithm, which is one of the core components of their healthcare platform.
Where is HoneyNaps based?
HoneyNaps is headquartered in Seoul, South Korea (Gangnam-gu), with a U.S. office in Boston, MA, and R&D collaboration with Yonsei University.
